Prosecution Insights
Last updated: September 20, 2026
Application No. 18/817,313

OVERTUBE

Final Rejection §103
Filed
Aug 28, 2024
Priority
Aug 29, 2023 — JP 2023-139259
Examiner
CAREY, MICHAEL JAMES
Art Unit
3795
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Fujifilm Holdings Corporation
OA Round
2 (Final)
84%
Grant Probability
Favorable
3-4
OA Rounds
3m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
513 granted / 613 resolved
+13.7% vs TC avg
Moderate +12% lift
Without
With
+11.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
10 currently pending
Career history
629
Total Applications
across all art units

Statute-Specific Performance

§101
8.1%
-31.9% vs TC avg
§103
43.5%
+3.5% vs TC avg
§102
17.9%
-22.1% vs TC avg
§112
16.5%
-23.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 613 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments, see pgs. 3 and 6, filed 8/6/2026, with respect to the objection to the abstract have been fully considered and are persuasive. The objection of 5/7/2026 has been withdrawn. Applicant's arguments filed 8/6/2026 in regards to the 103 rejection of claim 1 have been fully considered but they are not persuasive. In regards to the applicant’s arguments that Tilson does not expressly teach that “the second region is softer than the second state of the first region,” the Examiner disagrees. Tilson is clear in teaching multiple vacuum chambers each with its own pressure line. Tilson further states that the overtube includes “multiple zones of rigidization (via chambers 5775)”. Tilson continues on to state that “Any vacuum zones that are in the flexible state can be steered or deflected in the direction of cable tension while the zones that are rigidized will remain in their position and not be deflected.” Therefore Tilson, at the very least, has taught a flexible state (first state of the first region) and a rigid state (second state of the first region). Tilson goes on further to state that “this design allows alternating of which zones are under vacuum and/or direction of steering to form very complex shapes and provide navigation through the anatomy with minimal looping.” Thus, in an alternating design with the first region being taught as 5775a and the second region being the adjacent vacuum zone 577b, Tilson teaches having a first region in a rigid state and second region in a flexible state. This second region is then “softer” that the second state (rigid state) of the first region. In regards to the applicant’s argument that the Examiner used impermissible hindsight to make the combination of Sugiyama, the Examiner has demonstrated that it is a fact that Tilson discloses the second region being softer than the second state of the first region. The Examiner in no way used the applicant’s disclosure to form this combination as Tilson not only teaches the limited structure of claim 1, but also the advantage of employing their design in an overtube used to navigate difficult anatomical paths. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 1 and 4-5 is/are rejected under 35 U.S.C. 103 as being unpatentable over WIPO Publication WO2012/043034 to Sugiyama (hereinafter “Sugiyama”) in view of US Patent Application Publication 2020/0178763 to Tilson (hereinafter “Tilson”). In regard to claim 1, Sugiyama discloses an overtube comprising: a supply and discharge port that is located on a proximal end side and through which a fluid is supplied and discharged (Elements 23a-b); a first region (Fig. 2, 20) that is located on a distal end side with respect to the supply and discharge port (see Fig. 1) and includes an outer tube (Element 27) having a flexibility, an inner tube (Element 26) having a flexibility, and a shape-deformable body (Element 25) that is deformable and is provided between the outer tube and the inner tube (see Fig. 2); wherein the first region is switchable between a first state in which the fluid is supplied to a space between the outer tube and the inner tube via the supply and discharge port and a second state that is stiffer than the first state and in which the fluid is discharged (see highlighted and underlined section of Sugiyama’s English translation which has been provided with this action) However, Sugiyama does not disclose a second region that is located on the distal end side of the first region. In regards to claims 1 and 4-5, Tilson discloses a dynamically rigidizing medical instrument comprising: Regarding claim 1, a first region (Element 5775a), a second region that is located on the distal end side with respect to the first region and includes the outer tube and the inner tube (Element 5775b-c, [0123][0124]), wherein the first region is switchable between a first state a second state that is stiffer than the first state and in which the fluid is discharged, and the second region is softer than the second state of the first region ([0123] [0124] teaches the use of multiple chambers supplied by a fluid to control the stiffness of multiple sections of the device. Therefore, Tilson has taught that multiple regions along the device can have stiffer or softer regions depending on the insertion path of the device.) Regarding claim 4, wherein the second region includes the shape-deformable body, and the second region is switchable between the first state in which the fluid is supplied to the space between the outer tube and the inner tube via the supply and discharge port and the second state in which the fluid is discharged ([0123][0124]) wherein the first state of the second region is softer than the first state of the first region, and the second state of the second region is softer than the second state of the first region ([0123] [0124] teaches the use of multiple chambers supplied by a fluid to control the stiffness of multiple sections of the device. Therefore, Tilson has taught that multiple regions along the device can have stiffer or softer regions depending on the insertion path of the device.) It would have been obvious before the effective filing date of the claimed invention to include the deformable second region such as that taught by Tilson in order to prevent the endoscope from looping which can cause damage within the colon (Tilson [0003]). Allowable Subject Matter Claims 6-13 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is an examiner’s statement of reasons for allowance: The prior art does not disclose the interlayer as described in Applicant’s claim 6. Specifically, Tilson is the closest piece of prior art showing an interlayer in Element 4399a, but does not disclose that this interlayer comes into contact with shape-deformable body in the second state so that the first region becomes stiff. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL JAMES CAREY whose telephone number is (571)270-7235. The examiner can normally be reached Monday-Friday (8am-5pm). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Carey can be reached at 571-270-7235. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL J CAREY/Supervisory Patent Examiner, Art Unit 3795
Read full office action

Prosecution Timeline

Aug 28, 2024
Application Filed
May 07, 2026
Non-Final Rejection mailed — §103
Aug 06, 2026
Response Filed
Aug 21, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733798
ENDOSCOPE COMPRISING A DOUBLE BRAKE FOR UP-DOWN AND LEFT-RIGHT
3y 2m to grant Granted Sep 15, 2026
Patent 12734359
NON-INVASIVE NERVE STIMULATION WITH MOBILE SOFTWARE APPLICATION
2y 6m to grant Granted Sep 15, 2026
Patent 12708774
SUBTHRESHOLD DIRECT CURRENT (DC) NERVE CONDUCTION BLOCK AFTER SUPRATHRESHOLD "PRIMING"
6y 1m to grant Granted Aug 18, 2026
Patent 12708309
IMPLANTABLE NEURAL INTERFACE
3y 6m to grant Granted Aug 18, 2026
Patent 12708771
Systems and Methods for Seizure Detection Using Compression-Enabled Joint Entropy Estimation
3y 4m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
84%
Grant Probability
96%
With Interview (+11.9%)
2y 4m (~3m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 613 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month